Artisan Mid Cap Fund highlights insulin pump leader Insulet
Global equities rebounded in Q2 2026, and the portfolio delivered strong absolute returns, outperforming the Russell Midcap Growth Index. Healthcare, led by biotech holdings, and consumer discretionary also drove gains. In its Q2 2026 investor letter, Artisan Mid Cap Fund highlighted Insulet, a market leader in insulin pumps with a tubeless automated delivery system.